Lexicon Pharmaceuticals (LXRX) Reports In-Line Q4 EPS

February 21, 2013 6:29 AM

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.05) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found